Earnings
The Hydroponics Company Limited, to be renamed THC Global Group Limited is pleased to provide an update to the market of its activities for the quarter ended 30 September 2018 (the Quarter).
Nanollose Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company’s cash position at the end of the quarter stood at $7.1m.
Ultragenyx Pharmaceutical Inc. today announced that it will host a conference call on Monday, November 5, 2018 at 5pm ET to discuss third quarter 2018 financial results and provide a corporate update.
BioArctic AB to publish the company’s Interim Report for the period January – September 2018 on Thursday, November 8, 2018 at 08:00 a.m. CET.
MorphoSys AG will publish its third quarter 2018 results on November 5, 2018 at 10:00pm CET (9:00pm GMT; 4:00pm EST).
AstraZeneca has spent the last seven years getting hammered by loss of patent protections on older drugs. However, this quarter marked a return to sales growth driven by high demand for its new drugs, especially in the oncology segment.
Plenty of biotech companies will be releasing their third-quarter financial reports next week. Let’s take a quick look at some of these companies and their top stories they reported through 3Q2018.
Pharnext SA announced today its financial results for first-half 2018.
PRESS RELEASES